dual sigma-1 and sigma-2 receptor antagonists (Esteve Pharmaceuticals)

N/A

Report date: 2025/03/18 18:13:27
NME

Base Information

Drug Namedual sigma-1 and sigma-2 receptor antagonists (Esteve Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSigma-2 receptor antagonists
TargetsSigma-2 receptor
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEsteve Pharmaceuticals Sa
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A